1-(2-hydroxy-4,6-bis(methoxymethoxy)phenyl)-3-(p-tolyl)prop-2-en-1-one | 1290638-46-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 1-(2-hydroxy-4,6-bis(methoxymethoxy)phenyl)-3-(p-tolyl)prop-2-en-1-one
• CAS: 1290638-46-8
• 化学式: C₂₀H₂₂O₆
• 分子量: 358.391
• InChiKey: JRKWUGJICMAWQX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.56
• 重原子数：
  26.0
• 可旋转键数：
  9.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  74.22
• 氢给体数：
  1.0
• 氢受体数：
  6.0

反应信息

• 作为反应物：
  描述：

  1-(2-hydroxy-4,6-bis(methoxymethoxy)phenyl)-3-(p-tolyl)prop-2-en-1-one 在 sodium acetate 作用下， 生成 5,7-Bis(methoxymethoxy)-2-(4-methylphenyl)chroman-4-one
  参考文献：
  名称：

  甘草素衍生物抗阿尔茨海默病活性的设计、合成和胆碱酯酶抑制试验

  摘要：

  海洋环境是发现功能材料的丰富资源，海藻因其在生物学和医学中的潜在用途而受到认可。甘草素已从马尾藻中分离和鉴定。为了寻找新的抗阿尔茨海默病活性，我们设计并合成了 32种 7-异戊二烯氧基-2,3-二氢黄烷酮衍生物 ( 3a-3p ) 和 5-羟基-7-异戊二烯氧基-2,3-二氢黄烷酮衍生物 ( 4a- 4p）作为基于甘草素作为先导化合物的胆碱酯酶抑制剂。对乙酰胆碱酯酶 (AChE) 和丁酰胆碱酯酶 (BuChE) 的抑制筛选表明，所有合成的化合物在体外均具有有效的 AChE 抑制活性，但对 BuChE 的抑制活性减弱至较弱. 动力学研究表明，化合物 4o 通过双重结合位点能力抑制 AChE。此外，所有化合物均显示出自由基清除作用。最后，4o在AChE活性位点的分子对接模拟与所得药理结果吻合较好。

  DOI：

  10.1016/j.bmcl.2021.128306
• 作为产物：
  描述：

  1-[2-羟基-4,6-双(甲氧基甲氧基)苯基]乙酮,2',4'-双(甲氧基甲氧基)-6'-羟基苯乙酮 在 sodium hydride 、 potassium hydroxide 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 49.0h， 生成 1-(2-hydroxy-4,6-bis(methoxymethoxy)phenyl)-3-(p-tolyl)prop-2-en-1-one
  参考文献：
  名称：

  作为 AKR1C3 有效抑制剂的天然查耳酮类似物

  摘要：

  天然存在的物质是药物开发的宝贵资源。在这方面，已知查耳酮通过各种机制或靶标是针对前列腺癌细胞系的抗增殖剂。根据文献和初步结果，我们旨在研究和优化一系列查耳酮抑制雄激素转化 AKR1C3 的效率，AKR1C3 已知会促进前列腺癌。总共合成了12种具有不同取代模式的查耳酮。通过进行酶测定和对接模拟，分析了与这些 AKR1C3 抑制修饰相关的结构-活性关系。此外，还评估了化合物的选择性和细胞毒性。在酶测定中，C-6'羟基化衍生物比C-6'甲氧基化衍生物活性更高。相反，C-4 甲基化比 C-4 羟基化活性更高。对接结果支持了这些发现，最活跃的化合物很好地适合结合位点，并与关键氨基酸残基表现出强烈的相互作用。最有效的抑制剂对 HEK293T 细胞没有细胞毒性，并且对主要参与类固醇激素代谢的 17β-羟基类固醇脱氢酶具有选择性。然而，它们抑制了类固醇代谢途径的几种酶。确定了增强 AKR1C3 对查耳酮

  DOI：

  10.3390/metabo12020099

文献信息

• Synthesis and Antidiabetic Activity of 5,7-Dihydroxyflavonoids and Analogs
  作者：Liu-Shuan Chang、Chun-Bao Li、Nan Qin、Mei-Na Jin、Hong-Quan Duan

  DOI：10.1002/cbdv.201100049

  日期：2012.1

  essential for the antidiabetic activity of flavonoids, we synthesized two series of flavonoids, 5,7‐dihydroxyflavanones and 5,7‐dihydroxyflavones. In a screening for potential antidiabetic activity, most of the flavonoids showed a remarkable in vitro activity, and compounds 1f, 2d, and 3c were significantly more effective than the positive control, metformin. The biological activity was mainly affected

  在一项评估黄酮类化合物抗糖尿病活性所必需的结构元素的研究中，我们合成了两个系列的黄酮类化合物，5,7-二羟基黄烷酮和 5,7-二羟基黄酮。在筛选潜在的抗糖尿病活性时，大多数黄酮类化合物显示出显着的体外活性，化合物 1f、2d 和 3c 明显比阳性对照二甲双胍更有效。生物活性主要受黄酮骨架环B部分结构修饰的影响。结果表明，5,7-二羟基黄酮类化合物可被认为是开发新的抗糖尿病先导化合物的有希望的候选物。
• Zhao, Dong-Hai; Sui, Xin; Qu, You-Le, Asian Journal of Chemistry, 2011, vol. 23, # 3, p. 1129 - 1132
  作者：Zhao, Dong-Hai、Sui, Xin、Qu, You-Le、Yang, Li-Ye、Wang, Xian、Guan, Li-Ping

  DOI：——

  日期：——
• Synthesis and studies on antidepressant activity of 2′,4′,6′-trihydroxychalcone derivatives
  作者：Xin Sui、Ying-Chun Quan、Yue Chang、Rui-Peng Zhang、Yin-Feng Xu、Li-Ping Guan

  DOI：10.1007/s00044-011-9640-2

  日期：2012.7

  In this study, we synthesized a series of 2',4',6'-trihydroxychalcone derivatives and evaluated their antidepressant activities. The results of the nine compounds showed significantly reduced times during the forced swimming test at a dose of 10 mg/kg, indicative of antidepressant activity. Among the compounds, 2-bromo-2',4',6'-trihydroxychalcone (3h) was found to be the most potent, and it was observed that compound 3h at dose of 10, 20, and 40 mg/kg significantly reduced the duration of immobility times in the FST and TST in mice 30 min after treatment.
• Potent CDC25B and PTP1B phosphatase inhibitors: 2′,4′,6′-trihydroxylchalcone derivatives
  作者：Shui-Lian Zhao、Zhou Peng、Xing-Hua Zhen、Hong-Guo Jin、Yan Han、You-Le Qu、Li-Ping Guan

  DOI：10.1007/s00044-014-1264-x

  日期：2015.6

  In this study, we examined a series of 2',4',6'-trihydroxychalcone derivatives for their inhibitory activity as inhibitors of CDC25B and PTP1B. The pharmacological results showed that all of the tested compounds significantly inhibited CDC25B and PTP1B phosphatase in vitro. Among them, three compounds 2, 6, and 7 had the best inhibition activity, with inhibition rates against CDC25B were 99.56, 99.68, and 99.63 %, respectively, and with inhibition rates against PTP1B were 98.99, 99.37, and 98.08 %, respectively, which is similar to reference drugs Na3VO4 and Oleanolic acid, respectively. Cytotoxic activity assays showed compounds 2, 6, and 7 are potent against HeLa and HCT116. Moreover, compound 6 delayed the potent antitumor inhibitory activity in a colo205 xenograft model in vivo.
• Design, synthesis and antidepressant activity evaluation 2′-hydroxy-4′,6′-diisoprenyloxychalcone derivatives
  作者：Li-Ping Guan、Dong-Hai Zhao、Yue Chang、Yu Sun、Xiao-Li Ding、Jing-Fei Jiang

  DOI：10.1007/s00044-013-0517-4

  日期：2013.11

  In this study, 14 2'-hydroxy-4',6'-diisoprenyloxychalcone compounds were synthesized and their antidepressant activities were evaluated using the forced swimming test. The pharmacological results showed that six compounds significantly reduced immobility times during the forced swimming test at a dose of 10 mg/kg, indicative of antidepressant activity. Among these, three compounds (4d, 4e, and 4g) exhibited better antidepressant activity, with reduced immobility time by 38.3, 34.0, and 27.4 %, respectively. For explanation of the putative mechanism of action, compounds 4e, 4g were tested in chemical induced models.